US Patent Application No: 2003/0073,669

Number of patents in Portfolio can not be more than 2000

N-heterocyclic derivatives as NOS inhibitors

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

N-Heterocyclic derivatives of the formula (I): 1 are described herein, as well as other N-heterocycles, as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
BERLEX LABORATORIES, INC.RICHMOND, CA8
PHARMACOPEIA DRUG DISCOVERY, INC.CRANBURY, NJ43

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arnaiz, Damian O El Sobrante, CA 35 212
Baldwin, John J Gwynedd Valley, PA 251 1450
Davey, David D El Sobrante, CA 51 475
Devlin, James J Foster City, CA 68 117
Dolle, Roland Ellwood III King of Prussia, PA 11 1
Erickson, Shawn David Leonia, NJ 49 159
McMillan, Kirk Trenton, NJ 21 47
Morrissey, Michael M Danville, CA 88 1213
Ohlmeyer, Michael HJ Plainsboro, NJ 9 94
Pan, Gonghua Groton, CT 26 41
Paradkar, Vidyadhar Madhav Somerville, NJ 20 34
Parkinson, John Martinez, CA 29 56
Phillips, Gary B Pleasant Hill, CA 61 559
Ye, Bin Moraga, CA 63 190
Zhao, Zuchun Pleasanton, CA 74 323

Cited Art Landscape

  • No Cited Art to Display

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PHARMACOPEIA, LLC (1)
6,919,347 Bradykinin B1 receptor antagonists 1 2002
* Cited By Examiner